Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide

Neurology

Volumn 61, Issue 6, 2003, Pages 859-861

  Van Camp, G ^a,b   Flamez, A ^a   Cosyns, B ^a   Goldstein, J ^a   Perdaens, C ^a   Schoors, D ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ANTIMIGRAINE AGENT; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOT ALKALOID; FENFLURAMINE; HERBACEOUS AGENT; LEVODOPA; PERGOLIDE; PHENTERMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VALVE SURGERY; HISTOPATHOLOGY; HUMAN; LUNG FIBROSIS; MALE; MITRAL VALVE REGURGITATION; PARKINSON DISEASE; PRIORITY JOURNAL; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

EID: 0141653014     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000083985.00343.F2     Document Type: Article

References (10)

1. Facca A, Sanchez-Ramos J. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Mov Disord 1996;11:327-329.
2. Schwarz J, Scheidtmann K, Trenkwalder C. Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa. Eur Neur 1997;37:236-238.
3. Trenkwalder C, Winkelmann J, Hundemer HP, et al. High-dose treatment of Parkinson's disease with pergolide. Mov Disord 2000;15:132. Abstract.
4. Bana DS, MacNeal PS, LeCompte PM, Shah Y, Graham JR. Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. Am Heart J 1974;88:640-655.
5. Misch KA. Development of heart valve lesions during methysergide therapy. BMJ 1974;2:365-366.
6. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581-588.
7. Seghatol FF, Rigolin VH. Appetite suppressants and valvular heart disease. Curr Opin Cardiol 2002;17:486-492.
8. Serratrice J, Disdier P, Habib G, Viallet F, Weiller PJ. Fibrotic valvular heart disease subsequent to bromocriptine treatment. Cardiol Rev 2002;10:334-336.
9. Bonucelli U, Colzi A, Del Dotto P. Pergolide treatment of patients with early and advanced Parkinson's disease. Clin Neuropharmacol 2002;25:1-10.
10. Pritchett AM, Morrison JF, Edwards WD, Schaff HV, Connolly HM, Espinosa RE. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002;77:1280-1286.